Los Angeles Times

Commentary: Mark Cuban won’t fix our drug pricing problem

Policymakers should look to value-based drug pricing— pricing drugs according to the health benefits they deliver, the authors write.

Mark Cuban, the billionaire “Shark Tank” celebrity and Dallas Mavericks owner, is getting attention again — this time for his Mark Cuban Cost Plus Drug Co., which seeks to reduce prescription drug prices for Americans. A new study finds that Medicare could have saved $3.6 billion in 2020 if it had paid Mark Cuban drug prices.

This finding has been hailed as big news, reflecting the fact that Americans reliably consider prescription drug costs a high-priority issue. CBS reported that Cuban aims to turn the industry “upside down.”

You’re reading a preview, subscribe to read more.

More from Los Angeles Times

Los Angeles Times4 min read
California Exodus Left A Gaping Population Hole. Can The Golden State Bounce Back?
Despite a recent uptick in population, California still has a long way to go to make up for the exodus that began in 2019 and accelerated during the pandemic. Though the state population grew 0.17% in 2023 — the first year of growth since the COVID-1
Los Angeles Times4 min readAmerican Government
Jackie Calmes: Whatever Big Oil Wants, Big Oil Gets. As Long As It Bankrolls Trump
What better sign could there be that we’re drowning in political outrage, that we’re inured to it, than this: A national newspaper scooped this month that Donald Trump gathered about two dozen oil industry executives for a chopped steak dinner at his
Los Angeles Times8 min read
Sammy Roth: Meet The Comedians Telling Hilarious Jokes About Climate Change
LOS ANGELES — Lots of people enjoy laughing at billionaires — but it wasn’t just any billionaires who were the targets of Esteban Gast’s recent comedic jabs at the Crow, an intimate comedy club just off Metro’s E Line tracks in Santa Monica. After ad

Related Books & Audiobooks